NCT03470350 Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT03465878 A Study of LY900014 in Participants With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT03459612 A Study of Lasmiditan on Simulated Driving Performance in Healthy Participants Status COMPLETED Phase PHASE1
NCT03449433 A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT03448419 This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms Status COMPLETED Phase PHASE3
NCT03448406 This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms. Status COMPLETED Phase PHASE3
NCT03443024 A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03435081 A Study of Baricitinib (LY3009104) in Adult Participants With Moderate to Severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT03433677 A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT03432286 A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03428100 A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable Status COMPLETED Phase PHASE3
NCT03421379 A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT03418493 A Study of LY3316531 in Healthy Participants and in Participants With Psoriasis Status COMPLETED Phase PHASE1
NCT03414047 A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer Status COMPLETED Phase PHASE2
NCT03407118 A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE1